Monday, January 10, 2022

Molnupiravir benefits outweigh risk among Covid patients: Experts

An expert panel of the Central Drugs Standard Control Organisation had recently approved the antiviral Molnupiravir for restricted use in emergency situations, However, ICMR has raised concern over its side effects.

from Zee News :Zee News - Health https://ift.tt/3HVJTx0
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

India reports first known case of MYSM1-related bone marrow failure syndrome in child

Doctors have treated what is believed to be India’s first known case of MYSM1-related bone marrow failure syndrome, a very rare inherited d...